Market access issues for transgenic plants in Canada and abroad
Languages of publication
In this paper the factors affecting the commercialization of ag-biotech products in Canada destined for international markets. Public acceptance issues, lack of internationally harmonized regulatory systems and data requirements, politicized regulatory systems, intellectual property rights, unclear and inconsistent labeling laws, and the current uncertainty cultivated by the United Nations Convention on Biological Diversity (CBD) Biosafety Protocol, all contribute to market access barriers for Genetically Modified Organisms (GMOs) are discussed.
Publication order reference
B. Anderson, Aventis CropScience, Canada Co., 203-407 Downey Road, Saskatoon, Saskachewan S7N 4L8, Canada, e mail: firstname.lastname@example.org